Grant will bolster research into the use of stem cells to enhance T cell therapy

Tyler Staab was the first patient seen at the Norman Fixel Institute for Neurological Diseases at UF Health, which opened its doors to the public

In The Conversation, Drs. Katharina Busl and Carolina Maciel weigh in on a new study suggesting that brain activity measured by EEG may provide a key indicator to predict a patient’s likelihood of recovering from an acute brain injury.

Dr. Catherine Flores will expand her research into a new use of stem cells to enhance the clinical effectiveness of adoptive T cell therapy against brain tumors.

Dr. Matthew Farrer, recognized for his work on the genetics of Parkinson’s disease, will join UF Health on Sept. 1.

In the Conversation, Dr. Steven DeKosky weighs in on a new report discouraging the use of dietary supplements to prevent cognitive decline, dementia or Alzheimer's.

State-of-the-art building will feature some of the foremost experts in Parkinson’s and other neurological conditions.

Collaborators from the Fixel Institute and MBI will pilot a novel, low-cost intervention to improve Parkinson’s symptoms.

In the journal JAMA Neurology, Dr. Michael Okun discusses the challenge of selecting an appropriate DBS system for an individual patient.

Dr. James Wymer among national team of researchers to identify novel pathway for potential treatment of the disfiguring condition, neurofibromatosis 1.